HomeCoronary diseaseChronic Ischemic cardiopathy

Chronic Ischemic cardiopathy

FAVOR III Europa Sub-Analysis: Coronary Revascularization Deferral Based On QFR vs FFR

When it comes to intermediate coronary lesion revascularization decision making, functional assessment is the recommended. At present,...

TENDERA: Comparing Conventional vs. Distal Transradial Occlusion for Coronary Interventions

Supported by robust data, favorably compared against the transfemoral, the transradial approach has consolidated as the safest...

TCT 2024 – ECLIPSE: Randomized Study of Orbital Atherectomy vs Conventional PCI in Severely Calcified Lesions

Coronary calcification is associated with stent under-expansion and increased risk of both early and late adverse events....

TCT 2024 | Use of Artificial Intelligence for Patients with Suspected Coronary Artery Disease

The current approach to chest pain mainly focuses on symptom characteristics, conducting functional tests for ischemia assessment....

Plaque Morphology and Stent Elongation Assessed by OCT

Second and third generation drug eluting stents (DES) have thin or ultrathin struts and a scaffold that...

Failed Thrombus Aspiration and Decreased Myocardial Perfusion in Patients with STEMI and High Thrombus Load

Half of the patients undergoing percutaneous transluminal coronary angioplasty (PTCA) in a setting of ST-segment elevation acute...

Long Term Outcomes of RIBS VI, a Study on Bioresorbable Stents in Patients with In-Stent Restenosis

The use of drug eluting stents (DES) is currently recommended for the percutaneous treatment of coronary artery...

ESC 2024 | REC-CAGEREE I Trial: Drug Coated Balloon with Bailout Stenting vs. Intended DES for de Novo Lesion Treatment

DES stenting is currently the standard treatment. The development of balloon technology and the coating drugs have...